SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
SGTX
Delisted
SGTX was delisted on the 10th of August, 2023.
33 hedge funds and large institutions have $8.5M invested in Sigilon Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
-4
Holders Change %
-10.81%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
6
Reduced
13
Closed
6
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
+$8K
Top Buyers
Top Sellers
| 1 |
1
Millennium Management
New York
|
$116K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$0 |
| 3 |
3
Renaissance Technologies
New York
|
$79K |
| 4 |
4
State Street
Boston,
Massachusetts
|
$21K |
| 5 |
5
Morgan Stanley
New York
|
$15K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| $5K | -$374 | -52 | -7% |
|
27
Federated Hermes
Pittsburgh,
Pennsylvania
| $2K | -$182 | -30 | -8% |
|
28
Barclays
London,
United Kingdom
| $1K | – | – | – |
|
|
29
Citadel Advisors
Miami,
Florida
| – | -$39K | -3,603 | Closed |
|
30
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$1K | -115 | Closed |
|
31
Legal & General Group
London,
United Kingdom
| – | -$1K | -95 | Closed |
|